LncRNA SNHG10 Facilitates Hepatocarcinogenesis and Metastasis by Modulating Its Homolog SCARNA13 via a Positive Feedback Loop

Abstract

Understanding the roles of noncoding RNAs (ncRNA) in tumorigenesis and metastasis would establish novel avenues to identify diagnostic and therapeutic targets. Here, we aimed to identify hepatocellular carcinoma (HCC)-specific ncRNA and to investigate their roles in hepatocarcinogenesis and metastasis. RNA-seq of xenografts generated by lung metastasis identified long noncoding RNA small nucleolar RNA host gene 10 (SNHG10) and its homolog SCARNA13 as novel drivers for the development and metastasis of HCC. SNHG10 expression positively correlated with SCARNA13 expression in 64 HCC cases, and high expression of SNHG10 or SCARNA13 was associated with poor overall survival. As SCARNA13 showed significant rise and decline after overexpression and knockdown of SNHG10, respectively, we hypothesized that SNHG10 might act as an upstream regulator of SCARNA13. SNHG10 and SCARNA13 coordinately contributed to the malignant phenotype of HCC cells, where SNHG10 served as a sponge for miR-150-5p and interacted with RPL4 mRNA to increase the expression and activity of c-Myb. Reciprocally, upregulated and hyperactivated c-Myb enhanced SNHG10 and SCARNA13 expression by regulating SNHG10 promoter activity, forming a positive feedback loop and continuously stimulating SCARNA13 expression. SCARNA13 mediated SNHG10-driven HCC cell proliferation, invasion, and migration and facilitated the cell cycle and epithelial-mesenchymal transition of HCC cells by regulating SOX9. Overall, we identified a complex circuitry underlying the concomitant upregulation of SNHG10 and its homolog SCARNA13 in HCC in the process of hepatocarcinogenesis and metastasis. Significance: These findings unveil the role of a noncoding RNA in carcinogenesis and metastasis of hepatocellular carcinoma.

LncRNA GClnc1 promotes proliferation and invasion of bladder cancer through activation of MYC

“…We noticed that the in vivo effects are more pronounced than the in vitro effects in bladder cancer. Several studies (35)(36)(37)(38) have shown a similar pattern. One of the possible reasons is that we used transient transfected bladder cancer cells for in vitro assays, whereas steady transfected bladder cancer cells were used for in vivo experiments.…”

LncRNA SNHG14 contributes to the progression of NSCLC through miR‐206/G6PD pathway

“…LncRNAs have been reported to participate in the progression of various types of tumors, including lung cancer . For example, Yu et al .…”

Identification and analysis of long non-coding RNAs that are involved in inflammatory process in response to transmissible gastroenteritis virus infection

“…LncRNA H19 decreases the transcriptional activity of p53 [30]. LncRNA SNHG10 facilitates hepatocarcinogenesis and metastasis by modulating its homolog Small Cajal body-specific RNA 13 (SCARNA13) [31]. LncRNAs can also achieve the regulation of the expression of the target genes by recruiting some RNA-binding proteins [32].…”